Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Cardiac phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxia.

Wang Q, Donthi RV, Wang J, Lange AJ, Watson LJ, Jones SP, Epstein PN.

Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2889-97. doi: 10.1152/ajpheart.91501.2007. Epub 2008 May 2.

2.

Altering and analyzing glucose metabolism in perfused hearts of transgenic mice.

Donthi RV, Epstein PN.

Methods Mol Med. 2007;139:151-61.

PMID:
18287670
3.

Overexpression of hexokinase protects hypoxic and diabetic cardiomyocytes by increasing ATP generation.

Ye G, Donthi RV, Metreveli NS, Epstein PN.

Cardiovasc Toxicol. 2005;5(3):293-300.

PMID:
16244374
4.

Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes.

Kralik PM, Ye G, Metreveli NS, Shem X, Epstein PN.

Cardiovasc Toxicol. 2005;5(3):285-92. Erratum in: Cardiovasc Toxicol. 2006;6(1):79. Kralik, Patricia M [added]; Donthi, Rajakumar V [removed]; Shem, Xia [added].

PMID:
16244373
5.
6.

Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes.

Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, Epstein PN.

Diabetes. 2004 May;53(5):1336-43.

7.

Insulin in combination with vanadate stimulates glucose transport in isolated cardiomyocytes from obese Zucker rats.

Huisamen B, Donthi RV, Lochner A.

Cardiovasc Drugs Ther. 2001 Sep;15(5):445-52.

PMID:
11855663
8.

Elevated hexokinase increases cardiac glycolysis in transgenic mice.

Liang Q, Donthi RV, Kralik PM, Epstein PN.

Cardiovasc Res. 2002 Feb 1;53(2):423-30.

PMID:
11827693
9.

Overexpression of metallothionein reduces diabetic cardiomyopathy.

Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, Epstein PN.

Diabetes. 2002 Jan;51(1):174-81.

10.

Effect of vanadate and insulin on glucose transport in isolated adult rat cardiomyocytes.

Donthi RV, Huisamen B, Lochner A.

Cardiovasc Drugs Ther. 2000 Oct;14(5):463-70.

PMID:
11101193

Supplemental Content

Loading ...
Support Center